ATE88480T1 - Polypeptid und verfahren zu seiner herstellung. - Google Patents

Polypeptid und verfahren zu seiner herstellung.

Info

Publication number
ATE88480T1
ATE88480T1 AT88907358T AT88907358T ATE88480T1 AT E88480 T1 ATE88480 T1 AT E88480T1 AT 88907358 T AT88907358 T AT 88907358T AT 88907358 T AT88907358 T AT 88907358T AT E88480 T1 ATE88480 T1 AT E88480T1
Authority
AT
Austria
Prior art keywords
preparing
same
polypeptide
production
lipopolysaccharide
Prior art date
Application number
AT88907358T
Other languages
English (en)
Inventor
Takanori Nakamura
Sadaaki Iwanaga
Motonori Ohno
Kyosuke Miyazaki
Original Assignee
Seikagaku Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Kogyo Co Ltd filed Critical Seikagaku Kogyo Co Ltd
Application granted granted Critical
Publication of ATE88480T1 publication Critical patent/ATE88480T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT88907358T 1987-08-21 1988-08-19 Polypeptid und verfahren zu seiner herstellung. ATE88480T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20625887 1987-08-21
EP88907358A EP0343248B1 (de) 1987-08-21 1988-08-19 Polypeptid und verfahren zu seiner herstellung
PCT/JP1988/000823 WO1989001492A1 (en) 1987-08-21 1988-08-19 Novel polypeptide and method for preparing the same

Publications (1)

Publication Number Publication Date
ATE88480T1 true ATE88480T1 (de) 1993-05-15

Family

ID=16520353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88907358T ATE88480T1 (de) 1987-08-21 1988-08-19 Polypeptid und verfahren zu seiner herstellung.

Country Status (13)

Country Link
US (2) US5068314A (de)
EP (1) EP0343248B1 (de)
JP (1) JP2710653B2 (de)
KR (1) KR970001811B1 (de)
CN (1) CN1031193C (de)
AT (1) ATE88480T1 (de)
AU (1) AU642089B2 (de)
CA (2) CA1337781C (de)
DE (1) DE3880481T2 (de)
DK (1) DK193589A (de)
FI (1) FI92708C (de)
NO (2) NO175372C (de)
WO (1) WO1989001492A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation
US5594113A (en) * 1988-06-23 1997-01-14 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
WO1992004374A1 (fr) * 1990-09-11 1992-03-19 Seikagaku Kogyo Co., Ltd. Nouveau polypeptide et medicament anti-vih prepare a partir de ce polypeptide
EP0549102B1 (de) * 1991-12-25 1996-07-03 Maruha Corporation Reagenzien und Verfahren zur Bestimmung von Beta-Glucanen
JP3361830B2 (ja) * 1992-03-30 2003-01-07 生化学工業株式会社 抗菌性組成物及びそれを有効成分とする薬剤
EP0572688B1 (de) * 1992-05-30 1997-05-07 Predrag Dr.Sc. Sikiric BPC-Peptide, deren Herstellung und Verwendung
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
CA2112776C (en) * 1993-01-21 2002-11-12 Masakazu Tsuchiya Process for inhibiting activity of endotoxin
CA2146667A1 (en) 1993-08-18 1995-02-23 Adolf Hoess Lipopolysaccharide-binding and neutralizing peptides
DE69416824T2 (de) * 1993-10-14 1999-07-08 Seikagaku Corp., Tokio/Tokyo Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen
KR100257310B1 (ko) * 1996-12-21 2000-05-15 정몽규 트렁크 리드 개폐장치
US6011066A (en) * 1998-02-02 2000-01-04 Veterans General Hospital-Taipei Method for treating septic shock
CN100389140C (zh) * 2006-05-12 2008-05-21 北京理工大学 由聚肽-b-聚四氢呋喃-b-聚肽三嵌段共聚物制备纳米及微米级自组装体的方法
CA2768149A1 (en) * 2009-07-14 2011-01-20 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for hiv disease
CN108623659B (zh) * 2018-03-17 2021-09-14 中国海洋大学 一种氨基酸全部选用d型氨基酸的抗菌肽合成方法
WO2021183061A1 (en) * 2020-03-13 2021-09-16 Vet Products Research And Innovation Center Company Limited Antimicrobial peptides for inhibition of pathogenic microorganisms in digestive and respiratory tracts in animal

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663435A (en) * 1982-12-06 1987-05-05 Merck & Co., Inc. Bridged cyclic hexapeptide somatostatin analogs
CA1337781C (en) * 1987-08-21 1995-12-19 Takanori Nakamura Polypeptide from horseshoe crab exhibiting affinity for lipopolysaccharide and method of preparation

Also Published As

Publication number Publication date
CA1337782C (en) 1995-12-19
CN1031379A (zh) 1989-03-01
DE3880481T2 (de) 1993-09-09
AU642089B2 (en) 1993-10-07
CA1337781C (en) 1995-12-19
DE3880481D1 (de) 1993-05-27
FI891873A0 (fi) 1989-04-19
AU2311388A (en) 1989-03-09
US5416194A (en) 1995-05-16
WO1989001492A1 (en) 1989-02-23
NO175372B (no) 1994-06-27
JPH02500194A (ja) 1990-01-25
FI92708B (fi) 1994-09-15
CN1031193C (zh) 1996-03-06
JP2710653B2 (ja) 1998-02-10
AU620345B2 (en) 1992-02-20
US5068314A (en) 1991-11-26
NO891572D0 (no) 1989-04-18
FI92708C (fi) 1994-12-27
EP0343248A1 (de) 1989-11-29
KR890701624A (ko) 1989-12-21
NO175372C (no) 1994-10-05
NO940078L (no) 1989-05-09
NO940078D0 (no) 1994-01-10
EP0343248B1 (de) 1993-04-21
DK193589D0 (da) 1989-04-20
NO178663B (no) 1996-01-29
NO891572L (no) 1989-05-09
NO178663C (no) 1996-05-08
KR970001811B1 (ko) 1997-02-15
FI891873A7 (fi) 1989-04-19
DK193589A (da) 1989-06-16
AU1702892A (en) 1992-07-16

Similar Documents

Publication Publication Date Title
DE3880481D1 (de) Polypeptid und verfahren zu seiner herstellung.
FI114478B (fi) Menetelmä virtsasta peräisin olevan komponentti B: ksi kutsutun proteiinin valmistamiseksi
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
DE69130790T2 (de) Parathyroidhormon-Derivate
PT90512A (pt) Processo para a preparacao de peptidos anti-agregantes e de composicoes farmaceuticas que os contem
WO1995003327A3 (en) Peptides for neutralizing the toxicity of lipid a
US4658016A (en) Process for the preparation of pentapeptides having an action on the immune system and intermediate products for this process
Ozols Amino acid sequence of rabbit liver microsomal cytochrome b5
OA09696A (en) Novel polypeptides with affinity to lipopolysaccharides and their uses
AU1377092A (en) Peptides for treatment
Craig et al. Purity studies on polypeptide antibiotics: bacitracin
TAKAGI et al. Amino acid sequence of troponin C obtained from ascidian (Halocynthia roretzi) body wall muscle
Kuromizu et al. Reexamination of the primary structure of an antitumor protein, neocarzinostatin
DE69128416T2 (de) Fibronektin bindendes Peptid
US4716151A (en) Tripeptides and their use
WO1996003122A3 (en) Use of gabapentin in the treatment of anxiety and panic
Hooper et al. Histone III: II. ISOLATION AND SEQUENCES OF CHYMOTRYPTIC PEPTIDES FROM CALF THYMUS HISTONE III
US4637997A (en) Hexapeptide, process for obtaining II and the pharmaceutical compositions containing II
KR790001842B1 (ko) 신규 폴리펩티드의 제조법
Margalit et al. Subunit structure of canavalin
PT959895E (pt) Peptidos que reajem a anticorpos contra um peptido de consenso da familia de proteinas cs4-cfa/i
RU97114945A (ru) Белки против ожирения
FI961398L (fi) Menetelmä terapeuttisesti käyttökelpoisen peptidin valmistamiseksi

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee